Filter
1528
Text search:
Pharmaceutical
Assessment
Featured
139
391
Language
Document type
788
300
233
74
71
20
19
12
5
3
2
1
Countries / Regions
65
63
59
53
38
37
36
35
31
29
28
26
24
23
22
21
20
20
18
16
15
14
14
14
12
11
10
10
9
9
9
8
8
7
6
6
6
6
5
5
5
5
5
5
5
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
661
109
76
46
32
24
11
1
Toolboxes
154
134
131
89
69
68
45
38
36
28
28
26
26
22
14
11
9
7
6
5
2
1
1
1
AUDIT REPORT NO. 9-000-11-001-P | February 24, 2011
Antimicrobial resistance (AMR) is a multifaceted, international public health problem, which poses a direct threat to the safety of the population of South Africa. A national response is required to complement the development of a global plan, as articulated in the WHO’s draft resolution EB134/37
...
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an
...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
These guidelines present evidence-based recommendations and best practice statements on use of medically important antimicrobials in food-producing animals, based on the WHO list of critically important antimicrobials for human medicine (WHO CIA List). These guidelines aim primarily to help preserve
...
PMPB/INS-GUIDE/02
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
CHAPTER 206 | An Act to establish a national drug policy and a national drug authority to ensure the availability, at all times, of essential, efficacious and cost-effective drugs to the entire population of Uganda, as a means of providing satisfactory health care and safeguarding the appropriate us
...
Doc. No.: INS/GDL/001-(Annexes)
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
